News | Apartment-only CMBS deals emerge as Wall Street tests new playbook
Why this matters
Capital markets activity continues to be defined by the rotation from bank balance sheets to non-bank lenders. Private credit funds have raised record dry powder; banks have tightened CRE underwriting standards for the sixth consecutive quarter. The result is a market where well-sponsored deals clear, and marginal credit pays a meaningful spread to do so. For LPs, the allocation conversation has shifted decisively toward real estate debt, with equity allocations being deployed more selectively into operator-led platforms.
Editorial analysis · AI-assisted
External link. Real Estate Trail does not republish source content.
Related coverage — Capital
Gravis Listed Real Estate Fund Manager In Optimistic Mood
From automation to intelligence: Why enterprise AI mortgage operations are reshaping the industry
Artificial intelligence has introduced hundreds of tools to the mortgage industry, but many lenders are still struggling with rising costs, fragmented workflows and inconsistent productivity. According to Siddhartha A…
Mintos führt gebührenfreie ETF-Investitionen ab 1 € ein
BERLIN, 21. Juli 2026 /PRNewswire/ -- Mintos, eine europäische Multi-Asset-Investmentplattform für den langfristigen Vermögensaufbau, führt ETFs auf seiner Plattform ein. Anleger haben ab sofort Zugang zu über 1.000 d…
Mintos lance l'investissement gratuit en ETF, à partir de 1 €
BERLIN, 21 juillet 2026 /PRNewswire/ -- Mintos, plateforme européenne d'investissement multi-actifs dédiée à la constitution d'un patrimoine à long terme, lance les ETF sur sa plateforme. Les investisseurs peuvent dés…
Mintos launches free ETF investing, starting from €1
BERLIN, July 21, 2026 /PRNewswire/ -- Mintos, a European multi-asset investment platform for long-term wealth building, is launching ETFs on its platform. Investors can now access over 1,000 of the most popular ETFs a…
Lupin Spins Out Two Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy
Aims to Raise Capital to Fund Global Clinical Studies for LNP7457 (PRMT5) & LNP8701 (SOS1) MUMBAI, India and NAPLES, Fla., July 21, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257)…